Promising NESP Phase 3 Data Presented at American Society of Nephrology Meeting
Promising NESP Phase 3 Data Presented at American Society of Nephrology Meeting
About this item
Full title
Promising NESP Phase 3 Data Presented at American Society of Nephrology Meeting
Author / Creator
Publisher
New York: Business Wire
Journal title
Business Wire, 1999, p.1
Language
English
Formats
Publication information
Publisher
New York: Business Wire
Subjects
More information
Scope and Contents
Contents
In a randomized controlled study of 522 hemodialysis and peritoneal dialysis patients conducted in Europe and Australia, maintenance of hemoglobin level, weekly dose requirement and the frequency of dose changes in the NESP and EPO groups were similar regardless of route of administration, even among NESP patients treated every other week. Specific...
Alternative Titles
Full title
Promising NESP Phase 3 Data Presented at American Society of Nephrology Meeting
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_445902730
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_445902730
How to access this item
Log in as a Library member
